Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Astria Therapeutics, Inc. ATXS
$12.65
+$0.56 (4.46%)
На 18:04, 12 мая 2023
+58.10%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
353012940.00000000
-
week52high
16.28
-
week52low
2.36
-
Revenue
0
-
P/E TTM
-5
-
Beta
0.91522400
-
EPS
-3.46000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:10
Описание компании
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Jefferies | Buy | 29 сент 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 19 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | A | 1038309 | 908265 | 19 дек 2022 г. |
| Morabito Christopher | A | 100000 | 100000 | 01 авг 2022 г. |
| Callori Fred | A | 8333 | 8333 | 09 июн 2022 г. |
| LAPOINTE ANTHONY GREGG | A | 8333 | 8333 | 09 июн 2022 г. |
| Cole Hugh M | A | 8333 | 8333 | 09 июн 2022 г. |
| Beck Joanne T. | A | 8333 | 8333 | 09 июн 2022 г. |
| Violin Jonathan | A | 8333 | 8333 | 09 июн 2022 г. |
| BATE KENNETH | A | 8333 | 8333 | 09 июн 2022 г. |
| KISHBAUCH MICHAEL D | A | 8333 | 8333 | 09 июн 2022 г. |
| Harshbarger Benjamin | A | 55000 | 55000 | 01 мар 2022 г. |
Новостная лента
What Makes Astria Therapeutics, Inc. (ATXS) a Good Fit for 'Trend Investing'
Zacks Investment Research
27 дек 2022 г. в 10:31
If you are looking for stocks that are well positioned to maintain their recent uptrend, Astria Therapeutics, Inc. (ATXS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Astria Therapeutics: Tailwinds Building With Novel Treatment Paradigm
Seeking Alpha
24 дек 2022 г. в 00:38
ATXS has broken out from a 37-week price reversal. Hereditary angioedema is a rare genetic disorder characterized by recurrent episodes of swelling in various parts of the body.
These Were the Five Best and Worst Performing Healthcare Stocks in Q3 2022
24/7 Wall Street
24 окт 2022 г. в 21:21
The healthcare industry is now starting to shift its focus away from the coronavirus pandemic to work on its core activities.